Purpose: To determine whether trypan blue (TB) is toxic to cultured human retinal pigment epithelial (ARPE-19) cells, and whether hypothermia can protect ARPE-19 cells against TB toxicity. Methods: ARPE-19 cells were cultured and exposed to balanced salt solution as a control, while other cells were exposed to 0.05, 0.2, and 0.5% TB dye at 37 and 4°C for 5 and 30 min. The percentage of ARPE-19 cells that survived was determined by resazurin 1 day after the exposure. Results: A statistically significant decrease in the percentage of ARPE-19 cells surviving was found after exposure to 0.2 and 0.5% TB at any temperature or for any exposure duration (p < 0.01). The percentage of RPE cells surviving at 0.05% was not significantly different from that of controls except for a 30-min exposure at 37°C. The percentage of cells surviving at 4°C for a 5-min exposure to 0.5% TB and a 30-min exposure to 0.2 and 0.5% was significantly higher than that at 37°C under each condition (p < 0.01 for all). Conclusions: These results indicate that TB is toxic to human RPE cells, and the toxicity is dose- and exposure duration-dependent. Exposing the cells at 4°C had a protective effect against higher concentrations or longer exposure durations of TB compared to exposure at 37°C.

Keywords:
Hypothermia, protecting effect, Trypan blue toxicity, Retinal pigment epithelial cells
1.
Stalmans P, Feron EJ, Parys-Van Ginderdeuren R, Van Lommel A, Melles GR, Veckeneer M: Double vital staining using trypan blue and infracyanine green in macular pucker surgery. Br J Ophthalmol 2003;87:713–716.
2.
Teba FA, Mohr A, Eckardt C, Wong D, Kusaka S, Joondeph BC, Feron EJ, Stalmans P, Van Overdam K, Melles GR: Trypan blue staining in vitreoretinal surgery. Ophthalmology 2003;110:2409–2412.
3.
Vote BJ, Russell MK, Joondeph BC: Trypan blue-assisted vitrectomy. Retina 2004;24:736–738.
4.
Haritoglou C, Eibl K, Schaumberger M, Mueller AJ, Priglinger S, Alge C, Kampik A: Functional outcome after trypan blue-assisted vitrectomy for macular pucker: a prospective, randomized, comparative trial. Am J Ophthalmol 2004;138:1–5.
5.
Kwok AK, Yeung CK, Lai TY, Chan KP, Pang CP: Effects of trypan blue on cell viability and gene expression in human retinal pigment epithelial cells. Br J Ophthalmol 2004;88:1590–1594.
6.
Gale JS, Proulx AA, Gonder JR, Mao AJ, Hutnik CM: Comparison of the in vitro toxicity of indocyanine green to that of trypan blue in human retinal pigment epithelium cell cultures. Am J Ophthalmol 2004;138:64–69.
7.
Rezai KA, Farrokh-Siar L, Gasyna EM, Ernest JT: Trypan blue induces apoptosis in human retinal pigment epithelial cells. Am J Ophthalmol 2004;138:492–495.
8.
Rosomoff HL: Hypothermia and cerebral vascular lesions. I. Experimental interruption of the middle cerebral artery during hypothermia. J Neurosurg 1956;13:244–255.
9.
Mcdowall DG: The current usage of hypothermia in British neurosurgery. Br J Anaesth 1971;43:1084–1087.
10.
Rinkoff J, Machemer R, Hida T, Chandler D: Temperature-dependent light damage to the retina. Am J Ophthalmol 1986;102:452–462.
11.
Jabbour NM, Schepens CL, Buzney SM: Local ocular hypothermia in experimental intraocular surgery. Ophthalmology 1988;95:1687–1690.
12.
Norn MS: Vital staining of corneal endothelium in cataract extraction. Acta Ophthalmol (Copenh) 1971;49:725–733.
13.
Melles GR, de Waard PW, Pameyer JH, Houdijn Beekhuis W: Trypan blue capsule staining to visualize the capsulorhexis in cataract surgery. J Cataract Refract Surg 1999;25:7–9.
14.
Melles GR, de Waard PW, Pameijer JH, Beekhuis WH: Staining the lens capsule with trypan blue for visualizing capsulorhexis in surgery of mature cataracts. Klin Monatsbl Augenheilkd 1999;215:342–344.
15.
Norn MS: Per operative trypan blue vital staining of corneal endothelium: eight years’ follow-up. Acta Ophthalmol (Copenh) 1980;58:550–555.
16.
Haritoglou C, Gandorfer A, Schaumberger M, Priglinger SG, Mueller AJ, Gass CA, Kampik A: Trypan blue in macular pucker surgery: an evaluation of histology and functional outcome. Retina 2004;24:582–590.
17.
Narayanan R, Kenney MC, Kamjoo S, Trinh TH, Seigel GM, Resende GP, Kuppermann BD: Trypan blue: effect on retinal pigment epithelial and neurosensory retinal cells. Invest Ophthalmol Vis Sci 2005;46:304–309.
18.
Jackson TL, Hillenkamp J, Knight BC, Zhang JJ, Thomas D, Stanford MR, Marshall J: Safety testing of indocyanine green and trypan blue using retinal pigment epithelium and glial cell cultures. Invest Ophthalmol Vis Sci 2004;45:2778–2785.
19.
Machida S, Fujiwara T, Gotoh T, Hasegawa Y, Gotoh A, Tazawa Y: Observation of the ocular fundus by an infrared-sensitive video camera after vitreoretinal surgery assisted by indocyanine green. Retina 2003;23:183–191.
20.
Nakamura H, Hayakawa K, Imaizumi A, Sakai M, Sawaguchi S: Persistence of retinal indocyanine green dye following vitreous surgery. Ophthalmic Surg Lasers Imaging 2005;36:37–45.
21.
Veckeneer M, van Overdam K, Monzer J, Kobuch K, van Marle W, Spekreijse H, van Meurs J: Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes. Graefes Arch Clin Exp Ophthalmol 2001;239:698–704.
22.
Tamai K, Toumoto E, Majima A: Protective effects of local hypothermia in vitrectomy under fluctuating intraocular pressure. Exp Eye Res 1997;65:733–738.
23.
Tamai K, Toumoto E, Majima A: Local hypothermia protects the retina from ischaemic injury in vitrectomy. Br J Ophthalmol 1997;81:789–794.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.